Treatment as Prevention¨

On Scruff, Coming Out About HIV Prevention Just Got a Little Bit Easier

Last month, Scruff, the popular mobile hookup app, unveiled new profile options that will allow users to disclose their safer-sex practices more easily. The drop down menu presents three HIV prevention methods: condoms, pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP). Scruff users can select one of those options (PrEP or condoms or TasP), select […]

On Scruff, Coming Out About HIV Prevention Just Got a Little Bit Easier Read More »

Priorities for HIV care: the perspectives of healthcare providers and patients

Virological suppression and co-morbidities are the main focus of consultations between HIV healthcare providers (HCPs) and their patients, according to results of a study conducted by NAM and presented to the recent 15th European AIDS Conference held in Barcelona. Almost 90% of HCPs said the main focus of appointments with patients taking antiretroviral therapy (ART)

Priorities for HIV care: the perspectives of healthcare providers and patients Read More »

Criador do Tratamento como Prevenção abre congressos em João Pessoa

O mŽdico e pesquisador argentino radicado no Canadá, Julio Montaner – criador da estratŽgia “Tratamento como Prevenção” (“Treatment as key to Prevention”/TasP) – fará a conferência de abertura do 10º Congresso de HIV/Aids e do 3° Congresso de Hepatites Virais “Novos Horizontes, Novas Respostas”, do MinistŽrio da Saúde: “Por que pensar no fim da epidemia

Criador do Tratamento como Prevenção abre congressos em João Pessoa Read More »

Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs

While epidemiologists and public health experts are excited by the potential of new hepatitis C drugs to limit onward transmission of the virus among people who inject drugs, the strategies ignore profound barriers to drug users engaging with healthcare and their broader needs. For ‘treatment as prevention’ to be ethical and acceptable to people who

Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs Read More »

Prominent AIDS Researcher Receives Winslow Medal; Sees End of Pandemic as “Almost Inevitable”

Since the early 1980s, HIV/AIDS has claimed tens of millions of lives. The pandemic has touched every corner of the world, affected young and old, rich and poor and men and women of all backgrounds. It has been one of the worst scourges in human history, Anthony S. Fauci, M.D., a leading HIV/AIDS researcher and

Prominent AIDS Researcher Receives Winslow Medal; Sees End of Pandemic as “Almost Inevitable” Read More »

Congresso de HIV/Aids e de Hepatites Virais acontece em novembro

A partir desta quarta-feira (21/10), o portal do Departamento de DST, Aids e Hepatites Virais (DDAHV) do MinistŽrio da Saúde publicará matŽrias semanais em preparação à abertura – em novembro – do 10º Congresso de HIV/Aids e do 3° Congresso de Hepatites Virais “Novos Horizontes, Novas Respostas”. Os dois eventos serão realizados entre os dias

Congresso de HIV/Aids e de Hepatites Virais acontece em novembro Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below